GEN Exclusives

More »

GEN News Highlights

More »
Jan 18, 2012

GEN Poll Voters Divided on Prospects for Growth of Emerging Bioclusters

  • When asked how much they foresee emerging bioclusters growing in 2012, voters were somewhat evenly split but mostly optimistic. By a bare plurality (33.3%), respondents predicted that nine emerging regions identified in a recent survey by a commercial real estate firm would grow “a great deal” this year, while almost as many (30.4%) thought the emerging bioclusters would grow “somewhat.” The latter group was outnumbered, however, by the 32.4% of respondents who said they foresaw “not much” growth for the up-and-coming regions, identified by Jones Lang LaSalle as Minneapolis, Raleigh-Durham, Seattle, Chicago, Denver, Houston, Florida, Atlanta, and Indianapolis.

    While the first three are pretty established, a stronger case can be made for the rest as emerging clusters. As active as all have been, however, they remain overshadowed by the San Francisco Bay Area as well as Boston and Cambridge, MA, as the weak economy of the past four years combined with cutbacks due to mergers and acquisitions have helped consolidate U.S. biopharma activity further within the nation’s largest life science clusters. The remaining 3.9% of respondents were undecided.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Ill Patients Access to Experimental Medicines?

More »